Emergent BioSolutions (EBS) Inventory Average (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Inventory Average of $335.5 million for Q1 2026, up 7.24% year-over-year from $312.8 million in Q1 2025, and down 4.1% quarter-over-quarter from $349.8 million in Q4 2025.
Emergent BioSolutions (EBS) Inventory Average (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Inventory Average history runs 16 years deep, the most recent figure standing at $335.5 million for Q1 2026.
- In Q1 2026, Inventory Average rose 7.24% year-over-year to $335.5 million; the TTM figure through Mar 2026 stood at $335.5 million (up 7.24% YoY), while the FY2025 annual figure was $327.6 million, up 2.26% from the prior year.
- Inventory Average for Q1 2026 stood at $335.5 million, down from $349.8 million in the prior quarter.
- The five-year high for Inventory Average was $476.8 million in Q3 2022, with the low at $312.8 million in Q1 2025.
- The 5-year median for Inventory Average is $347.4 million (2025), against an average of $357.9 million.
- The sharpest annual moves came in 2022 and 2023: Inventory Average advanced 26.99% in 2022, then slipped 25.72% in 2023.
- Emergent BioSolutions' Inventory Average stood at $439.4 million in 2022, then fell by 22.29% to $341.5 million in 2023, then dropped by 7.12% to $317.2 million in 2024, then rose by 10.29% to $349.8 million in 2025, then slipped by 4.1% to $335.5 million in 2026.
- Business Quant data shows EBS's Inventory Average at $335.5 million in Q1 2026, $349.8 million in Q4 2025, and $347.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | 315.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 315.60 Mn |
| Mar 31, 2026 | 335.50 Mn |
| Dec 31, 2025 | 349.85 Mn |
| Sep 30, 2025 | 347.45 Mn |
| Jun 30, 2025 | 326.30 Mn |
| Mar 31, 2025 | 312.85 Mn |
| Dec 31, 2024 | 317.20 Mn |
| Sep 30, 2024 | 320.10 Mn |
| Jun 30, 2024 | 325.45 Mn |
| Mar 31, 2024 | 331.15 Mn |
| Dec 31, 2023 | 341.50 Mn |
| Sep 30, 2023 | 354.20 Mn |
| Jun 30, 2023 | 361.10 Mn |
| Mar 31, 2023 | 359.30 Mn |
| Dec 31, 2022 | 439.45 Mn |
| Sep 30, 2022 | 476.85 Mn |
| Jun 30, 2022 | 413.10 Mn |
| Mar 31, 2022 | 372.60 Mn |
| Dec 31, 2021 | 354.55 Mn |
| Sep 30, 2021 | 375.50 Mn |